Literature DB >> 31237352

Pycnodysostosis: Natural history and management guidelines from 27 French cases and a literature review.

Varoona Bizaoui1, Caroline Michot1, Geneviève Baujat1, Cyril Amouroux2, Sabine Baron3, Yline Capri4, Martine Cohen-Solal5, Corinne Collet6, Anne Dieux7, David Geneviève8, Bertrand Isidor3, Sophie Monnot1, Massimiliano Rossi9,10, Anya Rothenbuhler11, Elise Schaefer12, Valérie Cormier-Daire1.   

Abstract

Pycnodysostosis is a lysosomal autosomal recessive skeletal dysplasia characterized by osteosclerosis, short stature, acro-osteolysis, facial features and an increased risk of fractures. The clinical heterogeneity of the disease and its rarity make it difficult to provide patients an accurate prognosis, as well as appropriate care and follow-up. French physicians from the OSCAR network have been asked to fill out questionnaires collecting molecular and clinical data for 27 patients issued from 17 unrelated families. All patients showed short stature (mean = -3.5 SD) which was more severe in females (P = .006). The mean fracture rate was moderate (0.21 per year), with four fractures in total average. About 75% underwent at least one surgery, with an average number of 2.1 interventions per patient. About 50% required non-invasive assisted ventilation due to sleep apnea (67%). About 29% showed psychomotor difficulties and 33% needed a school assistant or adapted schooling. No patient had any psychological evaluation or follow-up. Molecular data were available for 14 families. Growth hormone administration was efficient on linear growth in 40% of cases. We propose several axis of management, such as systematic cerebral MRI for Chiari malformation screening at diagnosis and regular psychological follow-up.
© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  CTSK; bone fragility; osteosclerosis; pycnodysostosis

Year:  2019        PMID: 31237352     DOI: 10.1111/cge.13591

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  7 in total

1.  PYKNODYSOSTOSIS (OSTEOPETROSIS ACRO-OSTEOLYTICA).

Authors:  Gregory S Schmidt; John P Schacht; Treyce S Knee; Mohamed K M Shakir; Thanh D Hoang
Journal:  AACE Clin Case Rep       Date:  2020-06-23

Review 2.  Cathepsins in the Pathophysiology of Mucopolysaccharidoses: New Perspectives for Therapy.

Authors:  Valeria De Pasquale; Anna Moles; Luigi Michele Pavone
Journal:  Cells       Date:  2020-04-15       Impact factor: 6.600

3.  Increased Bone Resorption during Lactation in Pycnodysostosis.

Authors:  Ineke D C Jansen; Socrates E Papapoulos; Nathalie Bravenboer; Teun J de Vries; Natasha M Appelman-Dijkstra
Journal:  Int J Mol Sci       Date:  2021-02-11       Impact factor: 5.923

4.  A novel missense variant in TRAPPC2 causes X-linked spondyloepiphyseal dysplasia tarda: A case report.

Authors:  Li Zhang; Jinling Wang; Guanping Dong; Dingwen Wu; Wei Wu
Journal:  Medicine (Baltimore)       Date:  2021-03-19       Impact factor: 1.817

5.  Genetic and Molecular Evaluation: Reporting Three Novel Mutations and Creating Awareness of Pycnodysostosis Disease.

Authors:  Khalda Sayed Amr; Hala T El-Bassyouni; Sawsan Abdel Hady; Mostafa I Mostafa; Mennat I Mehrez; Domenico Coviello; Ghada Y El-Kamah
Journal:  Genes (Basel)       Date:  2021-09-29       Impact factor: 4.096

6.  Clinical and genetic characterization of three Russian patients with pycnodysostosis due to pathogenic variants in the CTSK gene.

Authors:  Tatiana Vladimirovna Markova; Vladimir Kenis; Evgeniy Melchenko; Darya Guseva; Darya Osipova; Nailya Galeeva; Tatiana Nagornova; Elena Leonidovna Dadali
Journal:  Mol Genet Genomic Med       Date:  2022-03-21       Impact factor: 2.473

7.  Pycnodysostosis: A Growth Hormone Responsive Skeletal Dysplasia.

Authors:  Hafsa Omer Sulaiman; Nandu Kumar Sidramappa Thalange
Journal:  AACE Clin Case Rep       Date:  2021-03-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.